NDC 69102-108

Roweepra

Levetiracetam

Roweepra is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Owp Pharmaceuticals, Inc.. The primary component is Levetiracetam.

Product ID69102-108_68f61297-c3f6-4adf-b2b1-edfeb5b006c0
NDC69102-108
Product TypeHuman Prescription Drug
Proprietary NameRoweepra
Generic NameLevetiracetam
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2020-10-28
Marketing CategoryANDA / ANDA
Application NumberANDA078858
Labeler NameOWP Pharmaceuticals, Inc.
Substance NameLEVETIRACETAM
Active Ingredient Strength250 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 69102-108-01

120 TABLET in 1 BOTTLE (69102-108-01)
Marketing Start Date2020-10-28
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Roweepra" or generic name "Levetiracetam"

NDCBrand NameGeneric Name
69102-102ROWEEPRAROWEEPRA
69102-104ROWEEPRAROWEEPRA
69102-103ROWEEPRAROWEEPRA
69102-101ROWEEPRAROWEEPRA
69102-108RoweepraRoweepra
0054-0224LevetiracetamLevetiracetam
0121-0799LevetiracetamLEVETIRACETAM
0121-1598LevetiracetamLEVETIRACETAM
0121-2397LevetiracetamLEVETIRACETAM
0121-4799LevetiracetamLEVETIRACETAM
0121-4802LEVETIRACETAMLEVETIRACETAM
0143-9574LevetiracetamLevetiracetam
0143-9673LevetiracetamLevetiracetam
0228-2167LevetiracetamLevetiracetam
0378-5613Levetiracetamlevetiracetam
0378-5615Levetiracetamlevetiracetam
0378-5617Levetiracetamlevetiracetam

Trademark Results [Roweepra]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ROWEEPRA
ROWEEPRA
86634147 5209905 Live/Registered
OWP Pharmaceuticals, Inc.
2015-05-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.